Skip to main content
Supplement ScienceSupplementScience

Benefits of Betaine HCl

Evidence:Emerging
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Protein digestion — adequate stomach acid (pH 1.5-3.5) is required to activate pepsinogen into pepsin, the primary gastric protease; betaine HCl restores this pH in hypochlorhydric individuals
  • Mineral absorption — Sturniolo et al. (1991) showed that hypochlorhydria impairs calcium, iron, and vitamin B12 absorption; acid supplementation may improve absorption of these nutrients
  • Pathogen defense — gastric acid is the first-line defense against ingested pathogens; low acid increases risk of SIBO and enteric infections (Martinsen et al., 2005)
  • Functional dyspepsia — a small study (Yago et al., 2013, n=6) confirmed betaine HCl significantly re-acidified the stomach in subjects with pharmacologically-induced hypochlorhydria

What the Research Says

Betaine HCl is a commonly utilized supplement in integrative medicine for addressing suspected hypochlorhydria, despite limited rigorous clinical trial evidence. The underlying physiological rationale is well-established: stomach acid plays a critical role in digestion, nutrient absorption, and protection against pathogens, with its production diminishing as individuals age. A study by Yago et al. (2013) demonstrated that Betaine HCl effectively re-acidifies the stomach, significantly lowering gastric pH by 4.5 units in healthy volunteers with rabeprazole-induced hypochlorhydria. However, a notable evidence gap persists due to the absence of large randomized controlled trials (RCTs) evaluating clinical outcomes in patients with functional gastrointestinal disorders.

Martinsen et al. (2005) highlighted the importance of stomach acid as a barrier against infectious diseases, underscoring its role in maintaining gut health and immune defense. While Betaine HCl appears to be a reasonable intervention for suspected hypochlorhydria following exclusion of Helicobacter pylori infection and ulcers, further research is needed to establish its efficacy in diverse clinical populations.

Additionally, Ostojic et al. (2013) explored the co-administration of methyl donors with guanidinoacetic acid (GAA), finding that this combination significantly reduced hyperhomocysteinaemia compared to GAA alone. Although not directly related to Betaine HCl's role in hypochlorhydria, this study underscores the importance of considering nutrient interactions when evaluating supplementation strategies.

References

  1. RCTYago MR, Frymoyer AR, Smelick GS, et al. (2013). Gastric reacidification with betaine HCl in healthy volunteers with rabeprazole-induced hypochlorhydria. Molecular Pharmaceutics. DOI PubMed
  2. ReviewMartinsen TC, Bergh K, Waldum HL. (2005). Gastric juice: a barrier against infectious diseases. Basic & Clinical Pharmacology & Toxicology. DOI PubMed
  3. RCTOstojic SM, Niess B, Stojanovic M, Obrenovic M (2013). Co-administration of methyl donors along with guanidinoacetic acid reduces the incidence of hyperhomocysteinaemia compared with guanidinoacetic acid administration alone.. The British journal of nutrition. DOI PubMed